Gout Trial, Recruiting (NCT07343336)

Gout Trial, Recruiting NCT07343336 Sponsor: Lille Catholic University Condition: Gout

Printed from Voxsanity (voxsanity.com.au) — NCT07343336 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Gout

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 75 years old (inclusive)
You are willing and able to sign a consent form agreeing to take part
You are able to fast (go without eating or drinking) before giving biological samples
You are of Polynesian ancestry
You are covered by a social security (health insurance) scheme

If joining the general population group:

You did not take part in the 2021 TOPATA study
You are visiting a general practitioner (for any reason)

If joining the gout group:

You are being treated at the rheumatology clinic at Taaone Hospital Centre in Papeete by Dr Baptiste Gérard

If joining the tophaceous gout sub-group:

You have a form of gout where hard lumps (called tophi) have formed under your skin (confirm with trial site)

If joining the gout crisis sub-group:

You are within 48 hours of the start of a gout attack
You agree to come back one week after joining the study for a second blood and urine sample

If joining the 2021 follow-up group:

You took part in the TOPATA study in 2021
You provided genetic and blood samples during that 2021 study
At the time you joined the 2021 study, you either had high uric acid levels in your blood without gout symptoms, or you had neither high uric acid levels nor gout

Who may not be able to join:

You are unwilling or unable to understand and give your consent to take part
You have a physical condition that would prevent you from following the study procedures
A close family member (parent, child, or sibling) is already taking part in the study — though both members of a couple (e.g. husband and wife) may be allowed to participate
You are under legal guardianship or supervision
You are pregnant or breastfeeding

If applying for the general population group:

You are unable to return for follow-up sample collection if needed

If applying for the gout group:

You have a knee replacement (prosthesis)
You have another inflammatory joint or rheumatic disease (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tristan Pascart, Professor, GHICL

Phone: +33 3 20 22 59 31

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07343336

Sponsor: Lille Catholic University

Phase: Not Applicable

Status: Recruiting

Condition: Gout

Trial contact: +33 3 20 22 59 31

More information: https://clinicaltrials.gov/study/NCT07343336

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 75 years old (inclusive)
You are willing and able to sign a consent form agreeing to take part
You are able to fast (go without eating or drinking) before giving biological samples
You are of Polynesian ancestry
You are covered by a social security (health insurance) scheme

If joining the general population group:

You did not take part in the 2021 TOPATA study
You are visiting a general practitioner (for any reason)

If joining the gout group:

You are being treated at the rheumatology clinic at Taaone Hospital Centre in Papeete by Dr Baptiste Gérard

If joining the tophaceous gout sub-group:

You have a form of gout where hard lumps (called tophi) have formed under your skin (confirm with trial site)

If joining the gout crisis sub-group:

You are within 48 hours of the start of a gout attack
You agree to come back one week after joining the study for a second blood and urine sample

If joining the 2021 follow-up group:

You took part in the TOPATA study in 2021
You provided genetic and blood samples during that 2021 study
At the time you joined the 2021 study, you either had high uric acid levels in your blood without gout symptoms, or you had neither high uric acid levels nor gout

Who may not be able to join:

You are unwilling or unable to understand and give your consent to take part
You have a physical condition that would prevent you from following the study procedures
A close family member (parent, child, or sibling) is already taking part in the study — though both members of a couple (e.g. husband and wife) may be allowed to participate
You are under legal guardianship or supervision
You are pregnant or breastfeeding

If applying for the general population group:

You are unable to return for follow-up sample collection if needed

If applying for the gout group:

You have a knee replacement (prosthesis)
You have another inflammatory joint or rheumatic disease (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Lille Catholic University

Registry

ClinicalTrials.gov

Start date

2 September 2025

Est. completion

1 September 2027

Where this trial is recruiting

French Polynesia

Primary endpoints

GWAS-identified associations between population-enriched genetic variants and health-related traits

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov